SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040984
Filing Date
2023-08-10
Accepted
2023-08-10 08:31:21
Documents
81
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cadl-20230630.htm   iXBRL 10-Q 3234988
2 EX-10.1 cadl-ex10_1.htm EX-10.1 116973
3 EX-10.2 cadl-ex10_2.htm EX-10.2 112617
4 EX-31.1 cadl-ex31_1.htm EX-31.1 19703
5 EX-31.2 cadl-ex31_2.htm EX-31.2 19400
6 EX-32.1 cadl-ex32_1.htm EX-32.1 10899
7 EX-32.2 cadl-ex32_2.htm EX-32.2 11444
  Complete submission text file 0000950170-23-040984.txt   10528073

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cadl-20230630_cal.xml EX-101.CAL 42925
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cadl-20230630.xsd EX-101.SCH 69456
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cadl-20230630_def.xml EX-101.DEF 297545
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cadl-20230630_pre.xml EX-101.PRE 422930
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cadl-20230630_lab.xml EX-101.LAB 544064
75 EXTRACTED XBRL INSTANCE DOCUMENT cadl-20230630_htm.xml XML 1594469
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40629 | Film No.: 231157342
SIC: 2836 Biological Products, (No Diagnostic Substances)